Toggle Nav
Close
  • Menu
  • Setting

Anti-Siglec-2/CD22 Antibody (Pinatuzumab)

Catalog No.
F1197
Anti-Siglec-2/CD22 Antibody (Pinatuzumab)
Grouped product items
SizePriceStock Qty
100ug
$90.00
Ship with 3-5 days
1mg
$270.00
Ship with 3-5 days
5mg
$756.00
Ship with 3-5 days
50mg
$2,533.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Pinatuzumab (Anti-Siglec-2 / CD22) is a humanized IgG1 monoclonal antibody targeting CD22. It has potential anti-tumor activity and can be used in the study of non-Hodgkin's lymphoma. Molecular weight: 146.64 KD.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

146.64 kDa

Shipping

Dry ice

Cas No.

1639820-81-7

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Pinatuzumab

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P20273

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

Immobilized human CD22 His at 2 ug/mL can bind Anti-Siglec-2/CD22 Antibody (Pinatuzumab)

Target

Siglec-2 / CD22

Note

Please avoid freeze-thaw cycles.